Acute Coronary Syndrome KCMC

Not Applicable

Completed

• Conditions: Acute Coronary Syndrome
• Interventions: Other: Quality Improvement

• Registration Number: NCT04563546
• Lead Sponsor: Duke University

Brief Summary

The purpose of this study is to develop a quality improvement intervention to address barriers to evidence-based acute coronary syndrome (ACS) care in northern Tanzania. Patients who presented to Kilimanjaro Christian Medical Center (KCMC) will be asked to complete a survey about barriers and facilitators of health care. In addition the survey will be administered to all providers, policymakers, and administrators participating in in-depth interviews. Data from this survey will be used to develop a quality improvement intervention that will be piloted by KCMC staff. Six months after the pilot program is implemented providers, patients, and administrators will be interviewed for their perspectives on the program.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2020-09-21
• Study First Submitted QC: 2020-09-21
• Study First Posted: 2020-09-24
• Study Start: 2023-09-01
• Primary Completion: 2024-09-01
• Status Verified: 2024-10
• Study Completion: 2024-10-01
• Last Update Submitted: 2024-10-07
• Last Update Posted: 2024-10-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 577

Inclusion Criteria

• 18 years or older
• symptoms related to acute coronary syndrome
• myocardial infarction
• clinically sober
• able to communicate in Swahili or English

Read More

Exclusion Criteria

• medically unstable
• have a deteriorating condiction
• too critically ill to participate

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
MI Patients in northern Tanzania	Quality Improvement	Patients presenting to KCMC emergency department with acute MI

Primary Outcome Measures

Name	Time	Method
Acceptability as measured by the Acceptability of Intervention Measure (AIM)	Initial ED visit (baseline)	The AIM tool is a 4-question survey that evaluates the acceptability of an intervention. Responses to each question are on a 5-point Likert Scale (Strongly Agree=5, Agree=4, Neutral=3, Disagree=2, Strongly Disagree=1). Responses of "Strongly Agree" (5) and "Agree" (4) are considered to indicate a more acceptable intervention. The responses to each question will be averaged together to give an acceptability score between 1 and 5 for each respondent. The primary outcome will be the overall mean acceptability score among respondents. A mean acceptability score \>= 4 will be considered to indicate acceptability.

Secondary Outcome Measures

Name	Time	Method
Patients with ACS taking aspirin 30 days after enrollment	30 days after enrollment	Percentage of patients taking aspiring at 30 days
Patients presenting with chest pain or shortness of breath who undergo ECG and cardiac biomarker testing during their ED stay	Initial ED visit (baseline)	Percentage of patients with these symptoms who undergo ECG and cardiac biomarker testing
Survival of ACS patients at 30 days after enrollment	30 days after enrollment	Percentage of patients who have survived at 30 days
Aspirin administration	Initial ED visit (baseline)	Percent of ED patients diagnosed with acute coronary syndrome receiving aspirin.

Trial Locations

Locations (1)

Duke University Hospital; 🇺🇸 Durham, North Carolina, United States